Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

Precision medicine defines the attempt to identify the most effective approaches for specific
subsets of patients based on their genetic background, clinical features, and environmental …

Background. Nonalcoholic fatty liver disease (NAFLD) is commonly observed in patients
with type 2 diabetes (T2D). Semaglutide, a glucagon-like peptide 1 receptor agonist, may …

Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia,
hyperglycemia, and hypertension. It should be noted that the occurrence of MetS is closely …

Primary nonalcoholic fatty liver disease (NAFLD) is bi-directionally associated with the
metabolic syndrome and its constitutive features (“factors”: impaired glucose disposal …

Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss
strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty …

Background Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver
alterations that can result in severe disease and even death. Consumption of ultra …

The hypoestrogenic period after menopause and associated metabolic imbalance might
facilitate the onset of non-alcoholic fatty liver disease (NAFLD) and its progression. The …

Background A proposal has recently been advanced to change the traditional definition of
nonalcoholic fatty liver disease to metabolic-associated fatty liver disease (MAFLD), to reflect …

Abstract The Fatty Liver Index (FLI) is a non-invasive biomarker proposed, in 2006, by
Bedogni's group, to aid in identifying patients with suspected nonalcoholic fatty liver disease …